Merck & Co Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) Transcript
Okay. Great. Well, thanks, everybody, for joining us. Good afternoon. This is going to be a 25-minute discussion with Merck's EVP and President of MRL, or Merck Research Laboratories, Dr. Dean Li. I'm Seamus Fernandez, one of the biopharma team senior therapeutics analysts here at Guggenheim, and I'm really pleased to have Dr. Li join us as part of our fourth annual oncology conference. Unfortunately, still virtual, but I'm confident that when we do this again next year, we're going to be doing this in person. Boy, I hope that -- I'm touching wood as we speak. So hopefully, we'll be in the right place.
Questions & Answers
So while Dr. Li leads the company's worldwide human vaccines and therapeutics research development organization, in the spirit of today's discussion and focus, we are going to focus on oncology, in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
